Trials / Unknown
UnknownNCT03932123
Antibiotic Therapy for Early Onset Neonatal Sepsis
Efficacy and Safety of Antibiotics in the Treatment of Early Onset Neonatal Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 0 Days – 3 Days
- Healthy volunteers
- Not accepted
Summary
Antibiotic therapy for early onset neonatal sepsis recommended by international guidelines and relevant studies is only kind of treatment regimen that penicillin G/ penicillin/ampicillin combined with gentamicin as the first-line treatment regimen. However, it is not applicable to the clinical practice in many countries and regions. We aim to study efficacy and safety of antibiotics in the treatment of early onset neonatal sepsis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Piperacillin and tazobactam, azlocillin, latamoxef, meropenem, vancomycin,cefotaxime | Efficacy and safety of antibiotics |
Timeline
- Start date
- 2019-05-05
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2019-04-30
- Last updated
- 2021-04-20
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03932123. Inclusion in this directory is not an endorsement.